EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9

Minse Kim, Youngwoo Hwang iD, Seongyu Lim, Hyeon-Ki Jang iD, Hyun-Ouk Kim iD

Pharmaceutics · 11.09.2024 · 16 (9) · 1197

DOI: 10.3390/pharmaceutics16091197 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 11.09.2024. Verfasst von Minse Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University, Chuncheon 24341, Republic …. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea grant funded by the Korean government by Korea In-stitute of Planning, Ministry of Science and ICT, Global - Learning & Academic research institution for Master's PhD students, and Postdocs (LAMP) Program of the National Research Foundation of Korea(NRF) gran….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system is a gene-editing technology. Nanoparticle delivery systems have attracted attention because of the limitations of conventional viral vectors. In this review, we assess the efficiency of various nanoparticles, including lipid-based, polymer-based, inorganic, and extracellular vesicle-based systems, as non-viral vectors for CRISPR/Cas9 delivery. We discuss their advantages, limitations, and current challenges. By summarizing recent advancements and highlighting key strategies, this review aims to provide a comprehensive overview of the role of non-viral delivery systems in advancing CRISPR/Cas9 technology for clinical applications and gene therapy.

Schlagwörter

Stichwörter der Autor:innen

CRISPR/Cas9deliverynanoparticlenon-viral vectorviral vector

Autor:innen und Institutionen

  • Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University, Chuncheon 24341, Republic of Korea.
  • Department of Smart Health Science and Technology, Kangwon National University, Chuncheon 24341, Republic of Korea.
  • Department of Systems Immunology, Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea.
  • Multidimensional Genomics Research Center, Kangwon National University, Chuncheon 24341, Republic of Korea.

ORCID-Profile: Youngwoo Hwang, Hyeon-Ki Jang, Hyun-Ouk Kim

Förderung

  • National Research Foundation of Korea grant funded by the Korean government by Korea In-stitute of Planning
  • Ministry of Science and ICT
  • Global - Learning & Academic research institution for Master's PhD students, and Postdocs (LAMP) Program of the National Research Foundation of Korea(NRF) gran…
  • National Research Foundation of Korea
  • Global-Learning & Academic research institution
  • Postdocs (LAMP) Program of the National Research Foundation of Korea (NRF)

Zitieren

APA

Kim, M., Hwang, Y., Lim, S., Jang, H. K., & Kim, H. O. (2024). Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9. Pharmaceutics, 16(9), 1197. https://doi.org/10.3390/pharmaceutics16091197

Vancouver

Kim M, Hwang Y, Lim S, Jang HK, Kim HO. Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9. Pharmaceutics. 2024;16(9):1197. doi:10.3390/pharmaceutics16091197

BibTeX
@article{Kim2024,
  author = {Kim, Minse and Hwang, Youngwoo and Lim, Seongyu and Jang, Hyeon-Ki and Kim, Hyun-Ouk},
  title = {Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {9},
  pages = {1197},
  doi = {10.3390/pharmaceutics16091197}
}
Kostenlos starten →